logging in or signing up JAPANESE B Encephalitis doctorrao Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: Embed: Flash iPad Dynamic Copy Does not support media & animations Automatically changes to Flash or non-Flash embed WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 383 Category: Entertainment License: All Rights Reserved Like it (0) Dislike it (0) Added: September 08, 2012 This Presentation is Public Favorites: 1 Presentation Description JAPANESE B Encephalitis Comments Posting comment... Premium member Presentation Transcript JAPANESE B ENCEPHALITIS: JAPANESE B ENCEPHALITIS Dr.T.V.Rao MD Dr.T.V.Rao MD 1Japanese Encephalitis belongs to Genus Flavivirus: Flaviviridae Flavivirus The name is derived from the Latin ‘flavus’ Flavus means “yellow” Refers to yellow fever virus Enveloped Single stranded RNA virus Morphology not well defined Center for Food Security and Public Health Iowa State University - 2007 Japanese Encephalitis belongs to Genus FlavivirusGenus - Flavivirus: Genus - Flavivirus Japanese B encephalitis virus is Spherical, 40 – 60 nm in diameter Contain a positive sense Single stranded RNA, 11 kb in size RNA genome is infectious Several viruses in this group are related. Dr.T.V.Rao MD 3A Flavivirus: Japanese encephalitis ( previously known as Japanese B encephalitis is a disease caused by the mosquito -borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae . Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may occur Dr.T.V.Rao MD 4 A FlavivirusStructure of Virus: The outer envelope is formed by envelope (E) protein and is the protective antigen. It aids in entry of the virus to the inside of the cell. The genome also encodes several non-structural proteins also (NS1,NS2a,NS2b,NS3,N4a,NS4b,NS5). NS1 is produced as secretary form also. NS3 is a putative helicase, and NS5 is the viral polymerase. Dr.T.V.Rao MD 5 Structure of VirusHistory: 1870s: Japan “Summer encephalitis” epidemics 1924: Great epidemic in Japan 6,125 human cases; 3,797 deaths 1935: First isolated From a fatal human encephalitis case 1938: Isolated from Culex tritaeniorhynchus Center for Food Security and Public Health Iowa State University - 2007 HistoryHistory: 1940-1978 Disease spread with epidemics in China, Korea, and India 1983: Immunization in South Korea Started as early as age 3 Endemic areas started earlier 1983-1987: Vaccine available in U.S. on investigational basis Center for Food Security and Public Health Iowa State University - 2007 HistoryWhat causes encephalitis?: Viruses (most common) More than 100 different viruses can cause acute encephalitis Seasonal and geographic distribution can help narrow differential diagnosis Examples of common viruses: Arbovirus Enter viruses Mumps, Varicella Herpes simplex virus Influenza Rabies What causes encephalitis? *Note: A large number of reported cases of encephalitis are due to an unspecified causeJapanese Encephalitis: First discovered and originally restricted to Japan. Now large scale epidemics occur in China, India and other parts of Asia. Flavivirus, transmitted by culex mosquitoes. The virus is maintained in nature in a transmission cycle involving mosquitoes, birds and pigs. Most human infections are subclinical: the in apparent to clinical cases is 300:1 In clinical cases, a life-threatening encephalitis occurs. The disease is usually diagnosed by serology. No specific therapy is available. Since Culex has a flight range of 20km, all local control measures will fail. An effective vaccine is available. Japanese EncephalitisJapanese B virus Infection: Infection is caused by a flavivirus, a single stranded RNA virus. It is transmitted by the bite of the Culex tritaeniorhynchus mosquito. The virus multiplies at the site of the bite and in regional lymph nodes before viraemia develops. Viraemia can lead to inflammatory changes in the heart, lungs, liver, and reticuloendothelial system. Dr.T.V.Rao MD 10 Japanese B virus InfectionA leading cause of viral Encephalitis: Japanese encephalitis is the leading cause of viral encephalitis in Asia, with 30,000–50,000 cases reported annually. Case-fatality rates range from 0.3% to 60% and depends on the population and on age. Dr.T.V.Rao MD 11 A leading cause of viral E ncephalitisAnimal-Arthropod-Man Cycle: Animal-Arthropod-Man CycleCycle of Infection in Japanese B Viral Infection: Dr.T.V.Rao MD 13 Cycle of Infection in Japanese B Viral InfectionTransmission: Vector-borne disease Enzootic cycle Mosquitoes: Culex species Culex tritaeniorhynchus Reservoir/Amplifying hosts Pigs, bats Ardeid (wading) birds Possibly reptiles and amphibians Incidental hosts Horses, humans, others Center for Food Security and Public Health Iowa State University - 2007 TransmissionA Vector born- Arbovirus Infection: A Vector born- Arbovirus Infection Culex tritaeniorhynchus a rural Mosquito that breeds in rice fields, is the principle vector. In India in 1955 the virus were isolated from Culex vishnui mosquitoes in Vellore region in Tamil Nad u Dr.T.V.Rao MD 15Japanese Encephalitis (JE): Most important global cause of arboviral encephalitis with > 50,000 cases and 15,000 deaths reported each year. Only about 1 in 250 JE infections result in symptomatic illness. Primarily affects children 1 to 15 years of age. Incubation period is 5 to 14 days. Japanese Encephalitis (JE) If unrecognized, mortality is up to 30% with half of survivors sustain severe neurological sequelae.INCIDENCE : Leading cause of viral encephalitis in Asia with 30-50,000 cases reported annually Fewer than 1 case/year in U.S. civilians and military personnel travelling to and living in Asia Rare outbreaks in U.S. territories in Western Pacific Dr.T.V.Rao MD 17 INCIDENCEPowerPoint Presentation: Dr.T.V.Rao MD 18Cycle of Events in Japanese B Encephalitis: Dr.T.V.Rao MD 19 Cycle of Events in Japanese B E ncephalitisPass through two prominent Hosts: Pass through two prominent Hosts Herons act as reservoir hosts and pigs as amplifier hosts. Human infection is a tangential ‘dead end’ and infections are spread when the infected mosquitoes reach high density. Dr.T.V.Rao MD 20PowerPoint Presentation: Subcutaneous injection Regional lymph nodes Extraneural Tissues Connective tissue Striated muscle Pancreas Adrenal Smooth muscle Efferent lymphatics Thoracic duct Plasma Viremia Reticuloendothelial cell clearance Humoral antibody Olfactory epithelium Vascular endothelium Neural Parenchyma Neurons, Glia (?) CNS antibody lymphocytes, macrophage Cellular dysfunction Cellular lysis Inflammation ? ? Pathogenesis of Flavivirus Infections Fields Virology, Vol 1, Fourth Edition. Lippincott-Williams & Wilkins (Philadelphia), pp 1057, 2001Clinical Manifestations: The incubation period is 6 to 16 days. There is a prodrome of fever, headache, nausea, diarrhoea, vomiting, and myalgia, which may last for several days. This may be followed by a spectrum of neurological disease ranging from mild confusion, to agitation, to overt coma. Two thirds of patients have seizures. It is more common in children, while headache and meningism are more common in adults. Dr.T.V.Rao MD 22 Clinical ManifestationsPowerPoint Presentation: Lethargy Sudden fever Vomiting and diarrhea Tremors or convulsions Headache Change in consciousness Irritability or restlessness Common symptoms of encephalitisCan lead to Neurological damage: Tremor or other involuntary movements are common. Mutism has been described as a presenting symptom. So has a syndrome of acute flaccid paralysis. Fever resolves by the second week, and choreoathetosis or extra pyramidal symptoms develop as the other neurological symptoms disappear. Dr.T.V.Rao MD 24 Can lead to Neurological damageDiagnosis of Japanese B Encephalitis: The isolation of virus from Blood, CSF, or tissues. Detection of Arbovirus specific RNA in blood,CSF, or Tissue However very few reference laboratories can perform the isolation in view of the biosafety considerations Dr.T.V.Rao MD 25 Diagnosis of Japanese B EncephalitisSerology by ELISA: IgM capture enzyme-linked immunoassay (ELISA) of serum or CSF is the standard diagnostic test. Sensitivity is nearly 100% when both serum and CSF are tested. False-negatives may result if the samples are tested too early, as in the first week of illness. New IgM dot enzyme immunoassays for CSF and serum are portable and simple tests that can be used in the field. Compared with ELISA as the gold standard , the sensitivity and specificity are around 98 and 99% respectively. Dr.T.V.Rao MD 26 Serology by ELISAArbovirus Specific RNA detection: Viral RNA is extracted from serum or from suspected tissues of the patients or mosquito homogenates. The product is amplified by RTPCR and the products analyzed by restriction digestion and determined by nucleotide sequence of PCR product. The identified sequence is compared with nucleotide sequence found in Gene bank or other data bases Dr.T.V.Rao MD 27 Arbovirus Specific RNA detectionFalse Positive Tests: There is some cross-reactivity with other flavivirus and from Japanese encephalitis and yellow fever vaccinations. Dr.T.V.Rao MD 28 False Positive TestsJapanese Encephalitis B Vaccine: Japanese Encephalitis B Vaccine has been produced since 1992. The vaccine is effective but not without risks and the substantial risks of the disease and the risks of the vaccine have to be balanced , especially for stays of brief duration. These are discussed more fully in the article on that subject. As with malaria, prophylaxis must be supplemented by techniques to avoid being bitten by mosquitoes . Dr.T.V.Rao MD 29 Japanese Encephalitis B VaccinePreventive measures: Preventive measures include mosquito control and locating piggeries away from human dwellings A formalin inactivated mouse brain vaccine using the Nakayama strain has been employed in human immunization in Japan – Two doses at two week’s interval followed by a booster 6 – 12 months later constitute a full course. However the immunity was short lived Dr.T.V.Rao MD 30 Preventive measuresEmerging Vaccines for JE virus: Two vaccines are manufactured and distributed exclusively in People’s Republic of China Inactivated vaccine grown in primary hamster kidney cells Live attenuated vaccine (SA14-14-2) grown in hamster kidney cells The third is manufactured in Japan and distributed abroad by arrangement with Sanofi-Pasteur Licensed as JE-VAX R and is the only FDA approved vaccine for use in the U.S. Has been in wide use worldwide since the 1960’s Three subcutaneous injections over a month with a booster at 3 years 91% efficacy in a large field trial in Thailand Emerging Vaccines for JE virusVaccination: Live attenuated vaccine Used in equine and swine Successful for reducing incidence Inactivated vaccine (JE-VAX) Used for humans Japan, Korea, Taiwan, India, Thailand Used for endemic or epidemic areas Recommended for travelers Visiting endemic areas for > 30 days Center for Food Security and Public Health Iowa State University - 2007 VaccinationLater vaccines: A live attenuated vaccine has been developed in China from JE strain SA 14-14-2, passed through weanling mice The vaccine is produced in primary bay hamster kidney cells. Administered in two doses, one year apart, the vaccine has been reportedly effective in preventing clinical disease Dr.T.V.Rao MD 33 Later vaccinesSafety of Current JE Vaccine: Side effects “Generally inconsequential.” Local tenderness or mild systemic symptoms in 10-30% - Field’s virology No neurologic events in Japanese surveillance Infrequent allergic reactions in adult travelers Urticaria, angioedema, bronchospasm, erythema nodosum and e. multiforme Incidence varies in different reports: 2/1000 to 1% 14,000 US Marines, 11 pruritus, 26 urticaria History of urticaria after hymenoptera envenomation or other provocations caused a relative risk increase of 9.1 None of the reactions were severe or life threatening Case control study in Australia identified increased reaction risk if excessive alcohol consumption in 48 hours after vaccination (p= 0.005) Safety of Current JE VaccinePrevention: Vector control Eliminate mosquito breeding areas Adult and larvae control Vaccination Equine and swine Humans Personal protective measures Avoid prime mosquito hours Use of repellants containing DEET Center for Food Security and Public Health Iowa State University - 2007 PreventionRESEARCH PRIORITIES : Facilitate implementation of attenuated vaccine in unvaccinated populations in endemic areas Develop improved vaccines Identify risk factors for progression to symptomatic encephalitis and viral persistence Describe clinical features of JE in AIDS and determine its potential as an opportunistic infection Dr.T.V.Rao MD 36 RESEARCH PRIORITIESFollow me for More Articles of Interest on Infectious Diseases : Dr.T.V.Rao MD 37 Follow me for More Articles of Interest on Infectious DiseasesPowerPoint Presentation: Created by Dr.T.V.Rao MD for Medical and Paramedical Professionals in Developing World Email firstname.lastname@example.org Dr.T.V.Rao MD 38 You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.